SLU-PP-332 20mg — Vial Spec, Reconstitution Math & COA

SLU-PP-332 20mg Vial Configuration & Mass Overview

A 20mg vial of SLU-PP-332 represents a high-yield mass configuration designed specifically for high-throughput cellular screening, multi-plate in vitro assays, and extended preclinical research models requiring consistent batch concentration. Supplying 20 milligrams of highly purified synthetic Estrogen-Related Receptor (ERR) agonist in a single lyophilized cake, this format minimizes vial-to-vial variance across larger experimental runs while optimizing volumetric efficiency for automated liquid handling systems.

Primary investigators and laboratory procurement specialists typically select the 20mg unit size when designing multi-week cell culture series or comparative metabolic assays that demand substantial stock solutions. If your laboratory requires alternate unit sizes, oral research formats, or small-scale feasibility units, PX1 Research provides flexible supply options. You can explore specialized analytical options such as SLU-PP-332 Capsules 250mcg or inspect our entire catalog of analytical standards via /all-peptides.

All SLU-PP-332 research compounds distributed by PX1 Research are strictly designated for laboratory research use only. They are not intended for human or animal administration, diagnostic procedures, or therapeutic application. Maintaining strict adherence to laboratory safety and analytical compliance is mandatory across all experimental operations.

Molecular Mechanism & Receptor Target Profile

SLU-PP-332 is a novel, non-steroidal synthetic agonist targeting the Estrogen-Related Receptor (ERR) family, displaying potent activity across all three isoforms: ERRα, ERRβ, and ERRγ. Preclinical research indicates that ERRα plays a central regulatory role in cellular energy homeostasis, mitochondrial biogenesis, and oxidative phosphorylation gene networks. By binding to these orphan nuclear receptors, SLU-PP-332 functions as a molecular probe for investigating metabolic pathway up-regulation in specialized tissue cultures.

In vitro data demonstrate that activation of ERRα by synthetic ligands promotes the transcriptional coactivator PGC-1α pathway, leading to increased expression of enzymes involved in fatty acid beta-oxidation and electron transport chain efficiency. Researchers studying skeletal muscle culture lines, cardiac myocytes, and metabolic signaling pathways utilize SLU-PP-332 to observe changes in cellular oxygen consumption rate (OCR) and mitochondrial density without physical contractile stimulation.

Because ERR receptors lack endogenous small-molecule hormones in the classical sense, synthetic probes like SLU-PP-332 provide researchers with an unprecedented level of chemical control. Investigating these pathways in isolated preclinical models sheds light on fundamental bioenergetic mechanisms, cellular metabolic flexibility, and target gene expression profiles under varied nutrient conditions.

Volumetric Reconstitution Calculations for 20mg Mass Units

Accurate reconstitution of a 20mg lyophilized SLU-PP-332 cake is critical for achieving target micromolar or millimolar working concentrations in benchtop research. Depending on the assay protocol, investigators must calculate the precise volume of compatible laboratory diluent—typically dimethyl sulfoxide (DMSO) or specialized organic co-solvent buffers due to the lipophilic nature of the compound—to establish stock solutions.

Below are the primary volumetric concentration benchmarks for a 20mg (20,000 µg) net mass vial:

• 1.0 mL Diluent Addition: Yields a stock concentration of 20.0 mg/mL (20.0 µg/µL). • 2.0 mL Diluent Addition: Yields a stock concentration of 10.0 mg/mL (10.0 µg/µL). • 3.0 mL Diluent Addition: Yields a stock concentration of 6.67 mg/mL (6.67 µg/µL). • 4.0 mL Diluent Addition: Yields a stock concentration of 5.0 mg/mL (5.0 µg/µL).

To quickly verify custom solvent volumes, molarities, or diluent combinations for specific plate layouts, researchers should consult the interactive PX1 Research reconstitution calculator. Accurate volumetric planning ensures that solvent vehicles (such as final DMSO concentrations) remain below cytotoxic thresholds in working cell culture media.

Solvent Compatibility, Solubility Limits, and Aliquot Protocols

SLU-PP-332 exhibits limited solubility in pure aqueous buffers like phosphate-buffered saline (PBS) at high stock concentrations. To ensure complete dissolution of the 20mg lyophilized cake, laboratory protocols typically specify initial reconstitution in 100% anhydrous DMSO or ethanol, followed by step-down dilution into culture media or aqueous assay buffers immediately prior to use.

When preparing stock solutions from a 20mg vial, researchers must execute a structured aliquot protocol to preserve chemical integrity:

1. Complete Dissolution: Add the designated volume of sterile laboratory-grade DMSO to the 20mg vial. Gently vortex or invert at room temperature until the lyophilized solid is fully dissolved and the solution is completely clear. 2. Serial Aliquoting: Divide the concentrated stock into single-use, polypropylene microcentrifuge tubes (e.g., 50 µL to 200 µL aliquots) to prevent repeated freeze-thaw cycles. 3. Thermal Storage: Store aliquoted stock vials at -20°C for short-term evaluation (up to 3 months) or -80°C for extended research storage (up to 12 months). 4. Media Dilution: Ensure final working solutions in cell culture media contain ≤0.1% to 0.5% DMSO v/v to eliminate solvent-induced baseline cellular toxicity.

Subjecting reconstituted SLU-PP-332 solutions to multiple freeze-thaw cycles can induce precipitation or chemical degradation. Always inspect thawed stock solutions visually for phase separation or particulate matter prior to dosing assay wells.

Analytical Purity Verification: HPLC, MS, and COA Standards

To guarantee reproducible scientific outcomes across preclinical investigations, every batch of SLU-PP-332 produced for PX1 Research undergoes rigorous chemical validation in an ISO 17025 accredited laboratory environment. Quality control standards require a minimum purity threshold of ≥98.0% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).

In addition to RP-HPLC purity profiling, every manufacturing lot undergoes Mass Spectrometry (MS) to confirm exact molecular weight and structural identity. Endotoxin screening is conducted using Limulus Amebocyte Lysate (LAL) assays to confirm that endotoxin levels remain strictly below threshold parameters (<0.01 EU/µg), preventing confounding inflammatory cascades during sensitive in vitro cellular trials.

Every 20mg vial shipped is assigned a specific lot number matching an official, public Certificate of Analysis. Researchers can review, download, and archive lot-matched documentation directly by visiting our dedicated /coa portal. Access to transparent analytical data ensures that experimental results can be published with complete confidence in compound identity and mass purity.

Selecting Optimal Formats: 20mg Vials vs. Specialized Mass Variants

Determining whether a 20mg vial format or an alternative product configuration is suitable depends on the scale, duration, and method of your laboratory model. The 20mg lyophilized vial is ideal for high-density assay screening, automated pipetting workstations, and projects requiring high-concentration stock solution banks.

When evaluating experimental design requirements, consider the following parameters:

• High-Throughput Screening (20mg Vial): Optimal for multi-well plate studies (96-well or 384-well) evaluating metabolic fluxes across dozens of treatment conditions simultaneously. • Unit-Dose Solid Formats: Specialized research designs investigating non-solution handling or precise solid mass dispersion may utilize alternative physical preparations like SLU-PP-332 Capsules 250mcg. • Small-Scale Pilot Assays: If an experiment requires only single-plate exploratory validation, smaller overall unit masses may be selected to eliminate solvent storage times.

For comprehensive lab inventory planning, bulk procurement, or specialized custom mass fills, investigators can establish direct institutional accounts via our /wholesale portal.

Comparative Analysis: Metabolic Probes in the Strength & Endurance Cluster

Within preclinical metabolic research, SLU-PP-332 represents one of several distinct chemical approaches to modulating cellular energy expenditure, mitochondrial biogenesis, and lipid substrate utilization. Comparing SLU-PP-332 against other small-molecule metabolic research compounds highlights unique receptor affinities and intracellular signaling pathways.

For example, while SLU-PP-332 acts directly as a nuclear receptor agonist at ERRα/β/γ, compounds like 5-Amino-1MQ target cytosolic enzymes—specifically acting as a selective inhibitor of Nicotinamide N-methyltransferase (NNMT) to alter cellular NAD+ flux and energy metabolism. Concurrently, compounds such as SR9009 function as Rev-ErbA agonists, regulating circadian control over lipid metabolism and mitochondrial turnover.

Researchers evaluating mitochondrial gene expression networks often compare these distinct target classes in side-by-side in vitro models. Understanding the functional differences between nuclear receptor agonists (SLU-PP-332), enzymatic inhibitors (5-Amino-1MQ), and nuclear receptor synthetics (SR9009) allows investigators to isolate specific control nodes within cellular bioenergetics.

Experimental Protocol Considerations for In Vitro Cellular Assays

When integrating SLU-PP-332 into cell culture protocols, precise controls must be maintained to establish reliable baseline metrics. Because ERR activation impacts mitochondrial oxygen consumption, assays measuring metabolic flux (e.g., Seahorse XF Analyzers) require strict vehicle-control groups containing identical DMSO concentrations.

Preclinical literature demonstrates that typical in vitro concentration curves for SLU-PP-332 range between 1 µM and 10 µM in culture media, depending on cell type (e.g., C2C12 myotubes, primary hepatocytes, or 3T3-L1 adipocytes). Treatment durations typically span 24 to 72 hours to allow sufficient transcriptional upregulation of downstream ERR target genes such as *PPARGC1A*, *Acadm*, and *Cpt1b*.

Researchers can consult published literature and methodological syntheses within the PX1 Research /research library to review established cellular incubation protocols, gene expression markers, and assay validation techniques applicable to ERR agonist probes.

Supply Chain Integrity, Storage Protocols, and Shipping Standards

PX1 Research manufactures and packages all research compounds in USA-based, GMP-compliant facilities under strict quality controls. Lyophilized 20mg SLU-PP-332 vials are sealed under inert nitrogen atmospheres to protect the active constituent from moisture-induced degradation and atmospheric oxidation during transit.

Orders are dispatched with same-day shipping (Monday through Friday) directly from our centralized distribution facilities in California and Arizona. Upon arrival at the laboratory, lyophilized vials should be stored at -20°C in a desiccated environment. Under these conditions, the powder remains stable for up to 24 months without measurable loss of analytical purity.

Once reconstituted into liquid stock solution, aliquots must be protected from direct light exposure and maintained at -80°C for maximal stability. Adhering to these storage parameters ensures high analytical precision across all experimental series.